Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Onivyde pegylated liposomal (previously Onivyde)“
Suchtreffer
Begriffe & Kennungen
Onivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with 5-fluorouracil and leucovorin: The following adverse reactions
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX): The fo
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin: Fatal events were
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin: Grade 3 or 4 anaem
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin: Grade 3 or 4 leuko
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin: Grade 3 or 4 throm
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin: In NAPOLI-3, Infus
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin: In NAPOLI-3, renal
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin: In NAPOLI-3, safet
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Other special populations
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Overall, no major clinical differences in safety were reported between patients ≥ 65 years and patients < 65 y
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Patients with UGT1A1 allele
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Patients with hepatic impairment
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Summary of the safety profile
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Table 4: Adverse reactions reported in patients treated with ONIVYDE pegylated liposomal
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · The adverse reactions described in this section are derived from studies data and post-marketing experience of
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Thrombocytopenia
Eintrag öffnen